Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015;6(3):161-72.
doi: 10.1080/19490976.2015.1039223.

Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain

Affiliations
Comparative Study

Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain

Imane Allali et al. Gut Microbes. 2015.

Abstract

Colorectal cancer (CRC) is the third most common cancer in the world and the second leading cause of cancer deaths in the US and Spain. The molecular mechanisms involved in the etiology of CRC are not yet elucidated due in part to the complexity of the human gut microbiota. In this study, we compared the microbiome composition of 90 tumor and matching adjacent tissue (adjacent) from cohorts from the US and Spain by 16S rRNA amplicon sequencing in order to determine the impact of the geographic origin on the CRC microbiome. Data showed a significantly (P < 0.05) higher Phylogenetic Diversity (PD) for the US (PD Adjacent = 26.3 ± 5.3, PD Tumor = 23.3 ± 6.2) compared to the Spanish cohort (PD Adjacent = 18.9 ± 5.9, PD Tumor = 18.7 ± 6.6) while no significant differences in bacterial diversity were observed between tumor and adjacent tissues for individuals from the same country. Adjacent tissues from the Spanish cohort were enriched in Firmicutes (SP = 43.9% and US = 22.2%, P = 0.0001) and Actinobacteria (SP = 1.6% and US = 0.5%, P = 0.0018) compared to US adjacent tissues, while adjacent tissues from the US had significantly higher abundances of Fusobacteria (US = 8.1% and SP = 1.5%, P = 0.0023) and Sinergistetes (US = 0.3% and SP = 0.1%, P = 0.0097). Comparisons between tumor and adjacent tissues in each cohort identified the genus Eikenella significantly over represented in US tumors (T = 0.024% and A = 0%, P = 0.03), and the genera Fusobacterium (T = 10.4% and A = 1.5%, P = <0.0001), Bulleida (T = 0.36% and A = 0.09%, P = 0.02), Gemella (T = 1.46% and A = 0.19%, P = 0.03), Parvimonas (T = 3.14% and A = 0.86%, P = 0.03), Campylobacter (T = 0.15% and A = 0.008%, P = 0.047), and Streptococcus (T = 2.84% and A = 2.19%, P = 0.05) significantly over represented in Spanish tumors. Predicted metagenome functional content from 16S rRNA surveys showed that bacterial motility proteins and proteins involved in flagellar assembly were over represented in adjacent tissues of both cohorts, while pathways involved in fatty acid biosynthesis, the MAPK signaling pathway, and bacterial toxins were over represented in tumors. Our study suggests that microbiome compositional and functional dissimilarities by geographic location should be taken in consideration when approaching CRC therapeutic options.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Comparison of phylogenetic diversity (PD) and species richness (S) between adjacent and tumor tissues from the US and Spain. * P < 0.05
Figure 2.
Figure 2.
Unweight UniFrac based Principal Coordinates Analysis (PCoA) of microbial communities associated with adjacent tissues and tumors from the US and Spain. ANOSIM and PERMANOVA generated parameters are indicated in each comparative plot.
Figure 3.
Figure 3.
Representation of relative abundances of bacterial phyla in adjacent and tumor according to tumor location in the intestinal tract.
Figure 4.
Figure 4.
Relative abundances of the most represented bacterial phyla in tumor and adjacent tissues in the US and Spain cohorts. Asterisks represent significant (P < 0.01) differences between groups.
Figure 5.
Figure 5.
Relative abundances of genera differentially represented in the tumors or non-tumor tissues of the US and Spanish cohorts. Asterisks represent significant (P < 0.05) differences between groups.
Figure 5.
Figure 5.
(Continued)

References

    1. GLOBOCAN Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 2012
    1. Colorectal Cancer - Facts and Figures American Cancer Society, 2011–2013:5–9.
    1. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44:1345–89; PMID:18280139; http://dx.doi.org/10.1016/j.ejca.2007.12.015 - DOI - PubMed
    1. Lopez-Abente G, Ardanaz E, Torrella-Ramos A, Mateos A, Delgado-Sanz C, Chirlaque MD, Colorectal Cancer Working G. Changes in colorectal cancer incidence and mortality trends in Spain. Ann Oncol 2010; 21(Suppl 3):iii76–82; PMID:20427364 - PubMed
    1. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312:1355–9; PMID:16741115; http://dx.doi.org/10.1126/science.1124234 - DOI - PMC - PubMed

Publication types

MeSH terms